Pharmacy Times , Ferruggia & Cohn interview (June 3, 2025), Streamlining GLP-1 Prior Authorizations ( [45] ) ( [7] )
The ladies here are absolutely wonderful
Who May Be at Greater Risk of Mood Changes People with a history of depression, eating disorders, or poorly controlled type 2 diabetes may be more vulnerable to mood changes and warrant closer monitoring during retatrutide treatment
This delay can lead to symptoms such as: Nausea Vomiting Early satiety (feeling full quickly) Bloating Abdominal discomfort Depending on the severity, gastroparesis can eventually cause malnutrition and other serious health concerns
The financial impact is not just the cost of the medication
Nausea, vomiting, and digestive discomfort are the most frequent